Nicola Heffron
Sales & Marketing at ALEXION PHARMACEUTICALS, INC.
Net worth: 108 155 $ as of 2024-04-29
Network origin in Nicola Heffron first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 14 | |
10
| Subsidiary | Biotechnology | 10 |
| Public Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nicola Heffron via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | General Counsel | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Compliance Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
| Brandeis University | College/University | Undergraduate Degree | |
| State University of New York College at Oneonta | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Masters Business Admin | |
| Haverford College | College/University | Undergraduate Degree | |
| Ramapo College of New Jersey | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Masters Business Admin | |
| University of Cardiff | College/University | Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| James P. Wilmot Cancer Center | Corporate Officer/Principal | ||
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | ||
| Astrazeneca Pharma Poland SP zoo | Corporate Officer/Principal | ||
SWOG
 SWOG Hospital/Nursing ManagementHealth Services SWOG operates cancer clinics. The non-profit company is based in San Antonio, TX. | Hospital/Nursing Management | Corporate Officer/Principal | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Life Sciences In Lublin | College/University | Doctorate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Seton Hall University School of Law | College/University | Graduate Degree | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Pharmaceuticals: Major | Chief Operating Officer | |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SCOPE FLUIDICS S.A. | Medical Specialties | Director/Board Member | |
| ERASCA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | Pharmaceuticals: Major | Director/Board Member | |
| Pfizer, Inc. /India/ | Corporate Officer/Principal | ||
| Proskauer Rose LLC | Corporate Officer/Principal | ||
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Civetta Therapeutics LLC
 Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
WuXi Advanced Therapies, Inc.
 WuXi Advanced Therapies, Inc. Pharmaceuticals: MajorHealth Technology Part of WuXi AppTec Co., Ltd., WuXi Advanced Therapies, Inc. is a contract testing development and manufacturing organization (CTDMO) based in Philadelphia, PA. The company offers integrated platforms to transform the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies for customers worldwide. The company's technologies, automation platforms, and service solutions advance pre-clinical research and accelerate the timeline to GMP manufacture, while integrated GMP manufacturing and testing platforms reduce time to market, maintaining high titers, high levels of quality assurance, and full regulatory compliance. Ultimately, their complete end-to-end solutions support pioneering companies to deliver breakthrough cell and gene therapies to the patients who need them. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CHIMERIC THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
| New York University School of Medicine | College/University | Doctorate Degree |
Statistics
International
| United States | 41 |
| United Kingdom | 4 |
| Poland | 4 |
| China | 2 |
| India | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Health Services | 3 |
| Electronic Technology | 2 |
| Finance | 2 |
Operational
| Corporate Officer/Principal | 48 |
| Director/Board Member | 39 |
| Undergraduate Degree | 16 |
| Chief Tech/Sci/R&D Officer | 15 |
| Independent Dir/Board Member | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Frédéric Chéreau | 17 |
| Marc Dunoyer | 16 |
| William R. Sellers | 14 |
| David Elkins | 13 |
| Gilla Kaplan | 12 |
| Justin Chakma | 9 |
| Wei Lin | 8 |
| Glen Frick | 8 |
| Philip Gregory | 7 |
| Steven H. Bernstein | 7 |
| Gianluca Pirozzi | 7 |
| Thomas Perone | 7 |
| Gerald F. Masoudi | 6 |
| George Matcham | 6 |
| Tamar Thompson | 6 |
- Stock Market
- Insiders
- Nicola Heffron
- Company connections
